BioCryst Pharmaceuticals Inc (BCRX)
7.05
-0.30
(-4.02%)
USD |
NASDAQ |
Nov 05, 16:00
7.06
+0.01
(+0.14%)
After-Hours: 19:13
BioCryst Pharmaceuticals Cash from Operations (Quarterly): -1.368M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.368M |
| March 31, 2024 | -53.68M |
| December 31, 2023 | -8.918M |
| September 30, 2023 | -19.90M |
| June 30, 2023 | -18.81M |
| March 31, 2023 | -47.51M |
| December 31, 2022 | -23.85M |
| September 30, 2022 | -32.44M |
| June 30, 2022 | -27.76M |
| March 31, 2022 | -77.80M |
| December 31, 2021 | -32.46M |
| September 30, 2021 | -23.28M |
| June 30, 2021 | -25.41M |
| March 31, 2021 | -61.01M |
| December 31, 2020 | -42.53M |
| September 30, 2020 | -38.26M |
| June 30, 2020 | -31.04M |
| March 31, 2020 | -23.28M |
| December 31, 2019 | -10.45M |
| September 30, 2019 | -27.64M |
| June 30, 2019 | -24.50M |
| March 31, 2019 | -27.00M |
| December 31, 2018 | -23.98M |
| September 30, 2018 | -35.03M |
| June 30, 2018 | -13.90M |
| Date | Value |
|---|---|
| March 31, 2018 | -19.65M |
| December 31, 2017 | -10.52M |
| September 30, 2017 | -12.43M |
| June 30, 2017 | -9.667M |
| March 31, 2017 | -8.527M |
| December 31, 2016 | -5.854M |
| September 30, 2016 | -17.56M |
| June 30, 2016 | -11.18M |
| March 31, 2016 | -18.84M |
| December 31, 2015 | -14.83M |
| September 30, 2015 | -12.66M |
| June 30, 2015 | 18.10M |
| March 31, 2015 | -3.726M |
| December 31, 2014 | -13.89M |
| September 30, 2014 | -8.60M |
| June 30, 2014 | -7.102M |
| March 31, 2014 | -8.959M |
| December 31, 2013 | -4.515M |
| September 30, 2013 | -7.922M |
| June 30, 2013 | -2.895M |
| March 31, 2013 | -11.20M |
| December 31, 2012 | -7.03M |
| September 30, 2012 | -11.78M |
| June 30, 2012 | -6.342M |
| March 31, 2012 | -12.25M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-77.80M
Minimum
Mar 2022
-1.368M
Maximum
Jun 2024
-31.57M
Average
-27.76M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Novavax Inc | 314.27M |
| AIM ImmunoTech Inc | -3.008M |
| Perspective Therapeutics Inc | -8.902M |
| Protalix BioTherapeutics Inc | -3.61M |
| Armata Pharmaceuticals Inc | -10.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.449M |
| Cash from Financing (Quarterly) | -1.966M |
| Free Cash Flow | -85.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0074 |
| Free Cash Flow to Equity (Quarterly) | 3.032M |
| Free Cash Flow to Firm (Quarterly) | 19.95M |
| Free Cash Flow Yield | -6.06% |